M16 M17
Conditions
Interventions
Group 1: Tailored implementation intervention (the type and content of the intervention will be developed in collaboration with key stakeholders through focus group discussions)
Group 2: Passive contr
Sponsors
Brandenburgische Technische Universität Cottbus-Senftenberg, Fachgebiet Therapiewissenschaften I
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Physiotherapists: regular treatment of patients diagnosed with hip and/or knee osteoarthritis Patients: a clinical diagnosis of hip and/or knee osteoarthritis confirmed by a physician, and a medical prescription for physiotherapy management
Exclusion criteria
Exclusion criteria: Physiotherapists: none Patients: osteoarthritis due to acute traumatic events (e.g. fractures, accidents); planned operations on the affected joint during the study period; comorbidities that restrict participation in physiotherapy (e.g. severe cardiovascular diseases, neurological diseases)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes include the evaluation of the acceptability (Acceptability of Intervention Measure, AIM), appropriateness (Intervention Appropriateness Measure, IAM) and feasibility (Feasibility of Intervention Measure, FIM) of the implementation intervention. In addition, barriers and facilitators will be assessed using the Barriers and Facilitators Assessment Instrument (BFAI). Data will be collected using standardised, web-based questionnaires, which will be administered to physiotherapists of the intervention group immediately after the intervention (T1-PT). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes evaluate the effectiveness of the implementation intervention and are collected from physiotherapists and patients in both the intervention and control group. Changes in the physiotherapists' attitudes towards evidence-based practice (Evidence-based Practice Inventory, EBPI) and knowledge of osteoarthritis guidelines (see Battista et al. 2021, DOI: 10.1186/s12891-021-04250-4 ) are assessed at three time points: prior to randomisation (T0-PT), after completion of the intervention (T1-PT) and at six-month follow-up (T2-PT). Data collection will be conducted using web-based questionnaires. In addition, changes in clinical practice will be evaluated based on treatment documentation. At the patient level, changes in pain (Numeric Rating Scale, NRS), function (Hip Disability and Osteoarthritis Outcome Score, HOOS; Knee Injury Osteoarthritis Outcome Score, KOOS) and health-related quality of life (European Quality of Life 5 Dimensions 5 Level, EQ-5D-5L) are assessed at three points: at the start of treatment (T0-Pat), after completion of all treatment sessions (T1-Pat) and after six months (T2-Pat). Knowledge about osteoarthritis will be assessed using the Osteoarthritis Knowledge Scale (OAKS) at T0-Pat and T2-Pat. Perceived changes in health status will be measured using the Global Rating of Change Scale (GRoC) at T1-Pat and T2-Pat. In addition, after the end of treatment (T1-Pat), patients use the Osteoarthritis Quality Indicator Questionnaire (OA-QI) to indicate which treatment they believe they have received. All secondary outcomes collected from patients are recorded using web-based questionnaires. | — |
Countries
Germany
Contacts
Public ContactCarolin Bahns
Brandenburgische Technische Universität Cottbus-Senftenberg, Fachgebiet Therapiewissenschaften I
Outcome results
None listed